Search

Supplemental material, sj-docx-1-msc-10.1177_09691413221092246 for Self-sampling for cervical screening offered at the point of invitation: A cross-sectional study of preferences in England by Hannah Drysdale, Laura AV Marlow, Anita Lim, Peter Sasieni and Jo Waller in Journal of Medical Screening

Supplemental material, sj-pdf-1-msc-10.1177_0969141320987271 for Cervical screening attendance and cervical cancer risk among women who have sex with women by Catherine L Saunders, Efthalia Massou, Jo Waller, Catherine Meads, Laura AV Marlow and Juliet A Usher-Smith in Journal of Medical Screening

Supplemental material, sj-pdf-2-msc-10.1177_0969141320987271 for Cervical screening attendance and cervical cancer risk among women who have sex with women by Catherine L Saunders, Efthalia Massou, Jo Waller, Catherine Meads, Laura AV Marlow and Juliet A Usher-Smith in Journal of Medical Screening

Objectives Understanding why some women actively decline cervical screening could contribute to tailored intervention development. We explored reasons for non-participation in cervical screening among women who had made an active decision not to attend in the future. We also explored interest in human papillomavirus self-sampling. Methods In a population-based survey of women in Great Britain, home-based computer-assisted interviews were carried out with screening eligible women. Women reported their intention to attend for screening when next invited. They endorsed predefined barriers to screening and indicated their interest in human papillomavirus self-sampling. Results Women who had actively declined screening and those who intended to go but were currently overdue (n=543) were included in this analysis. Women who had made an active decision not to be screened in the future were more likely to endorse the barriers ‘I have other more important things to worry about’ and to perceive screening to be of low relevance based on their sexual behaviour. Most participants (70%) indicated that they would be interested in human papillomavirus self-sampling. Interest in self-sampling was greater among those who reported having had a bad experience of screening in the past, were too busy or embarrassed to attend, or would not want a man to carry out the test. Conclusions Women who had made an active decision not to attend screening felt it was of low relevance to them and that they had more important things to worry about. Shifting the perceived cost–benefit ratio for these women by offering human papillomavirus self-sampling might increase screening participation in this group.